Regenerative Medicine Phoenix, AZ

Frequently Asked Questions

Is regenerative medicine covered by insurance?

Coverage varies by provider and specific treatment. Our staff can review financial options and discuss coverage details before your procedure.

Does PRP work for knee pain?

Many patients with knee discomfort stemming from osteoarthritis or injury experience meaningful relief and improved mobility after PRP therapy at Premier Pain Management Arizona. The treatment concentrates growth factors from a small sample of your own blood and delivers them precisely to the affected joint to help calm inflammation while supporting natural tissue repair. Results vary depending on the degree of joint changes, overall health, and how well the therapy fits into a broader care plan, which is why our specialists perform thorough evaluations to identify suitable candidates. This approach serves as a strong nonsurgical option for those aiming to reduce reliance on medications or avoid surgery.

How long does PRP take to work?

The healing response initiated by PRP injections commonly leads to noticeable improvements in pain levels and joint function starting around four to six weeks after the procedure. These benefits tend to build steadily as tissue regeneration takes place, often extending over the course of multiple months. At our practice serving the Phoenix area including Maryvale, Mesa, and Queen Creek, providers track progress closely and may recommend supportive steps such as targeted rehabilitation to help optimize outcomes during this window. Timelines differ by individual, so clear discussions with your care team help establish practical expectations.

What conditions does regenerative medicine treat?

Regenerative medicine options available through Premier Pain Management Arizona target a range of musculoskeletal challenges, including ongoing joint pain linked to osteoarthritis and damage to tendons or ligaments around major joints. Patients often seek these therapies for persistent issues in the knee, shoulder, hip, or along the spine, where the focus is on encouraging the body’s natural repair processes and easing chronic inflammation. By weaving biologic treatments into customized, multidisciplinary plans, our team helps address underlying contributors to discomfort rather than only managing symptoms. This integrated strategy works well for individuals across our Arizona locations who want alternatives to surgery or extended medication use while pursuing better long-term function.

Do studies show stem cell injections beat PRP for knee osteoarthritis?

No. Head-to-head trials in symptomatic knee osteoarthritis have not shown cell-based injections to be consistently superior to PRP on pain and function over 12 to 24 months. In a 2022 randomized study in the American Journal of Sports Medicine, patients improved in both groups, and imaging changes were also similar. That is why we do not treat “stem cells” as an automatic upgrade. The better question is whether your joint stage, prior response, and overall health make one starting point more appropriate than the other.

If results look similar, why consider a harvest procedure at all?

Because the procedures are not identical even when average trial scores look close. PRP is prepared from a blood draw. A cell-based option requires a small harvest from bone marrow or adipose tissue, then injection of that concentrate into the joint. We consider that extra step when milder options have plateaued, when the joint shows more advanced degenerative change that may need stronger cellular signaling, or when a combined plan is the point. We do not recommend harvest just because the name sounds more advanced.

Can PRP be done first and a cell-based injection later?

Yes. For many people with mild to moderate knee osteoarthritis, PRP is a reasonable first biologic because it stays office-based and the evidence does not require starting with harvest. If comfort and function improve enough, nothing further may be needed. If the response is incomplete after an appropriate interval, a cell-based injection can still be discussed. That sequence is a clinical decision after we see how your joint responds, not a package sold up front.

Does bone-on-bone arthritis still respond to these injections?

Sometimes, but much less reliably, and it is not what these treatments do best. When imaging shows bone-on-bone change, the main problem is often mechanical loss of joint space rather than inflammation we can reset with a biologic. Some patients still get a period of improved comfort. Many do not get a meaningful or lasting change, and the conversation may need to include other interventional options or whether a surgical referral is more honest. We decide that from your imaging and exam, not from the diagnosis name alone. Learn more about arthritis on our osteoarthritis page.

Will this regrow cartilage on an MRI?

Not in a consistent, large-scale way in human trials. Both PRP and cell-based injections help calm inflammation and improve comfort and movement. They have not been shown to rebuild a worn joint surface on MRI in the way many advertisements imply. If an X-ray or MRI already shows advanced cartilage loss, the goal of treatment is function and pain control, not reversing the picture. We will say that plainly before anyone books a procedure.

Is a combined PRP + cell-based plan automatically better?

No. Combining them can make sense in a personalized plan when we want platelet signaling and a cell-based concentrate in the same joint, but combining procedures is not automatically more effective. Extra steps mean extra recovery and cost without a guarantee of a better result. We use a combined approach when the joint findings and prior response support it, not as a default “more is better” package.